Showing results (621-630 of 3,540) with videos related to
Sort By:
Pageof 354
Chemical Biology & Drug Design|March 5, 2015
Inhibition of Acetylcholinesterase (AChE): A Potential Therapeutic Target to Treat Alzheimer's DiseaseYong Li, Xiao-Xiao Zhang, Li-Juan Jiang, et al.Chemical Biology & Drug Design|June 24, 2014
Synthesis and evaluation of salicylanilide derivatives as potential epidermal growth factor receptor inhibitorsMinhua Hu, Wenfeng Ye, Jiaming Li, et al.Chemical Biology & Drug Design|March 13, 2015
Insights into the Interaction Mechanism of Ligands with Aβ42 Based on Molecular Dynamics Simulations and Mechanics: Implications of Role of Common Binding Site in Drug Design for Alzheimer's DiseaseHarish S Kundaikar, Mariam S DeganiChemical Biology & Drug Design|July 28, 2012
Evaluation of perylenediimide derivatives for potential therapeutic benefits on cancer chemotherapyTaner Keskin, Belgin S Isgor, Yasemin G Isgor, et al.Chemical Biology & Drug Design|January 22, 2014
Unraveling the role of Arg4 and Arg6 in the auto-inhibition mechanism of GSK3β from molecular dynamics simulationLinkai Mou, Molin Li, Shao-Yong Lu, et al.Chemical Biology & Drug Design|January 23, 2014
Novel fragment-based QSAR modeling and combinatorial design of pyrazole-derived CRK3 inhibitors as potent antileishmanialsSukriti Goyal, Jaspreet K Dhanjal, Chetna Tyagi, et al.Chemical Biology & Drug Design|June 7, 2014
Design, synthesis and evaluation of rhodanine derivatives as aldose reductase inhibitorsYogesh P Agrawal, Mona Y Agrawal, Arun K GuptaChemical Biology & Drug Design|June 14, 2014
The potential roles of cell surface pHs in bioactive peptide activationLong Chen, Jun F LiangChemical Biology & Drug Design|June 14, 2014
Synthesis and evaluation of a new series of 3,5-bis((5-bromo-6-methyl-2-t-aminopyrimidin-4-yl)thio)-4H-1,2,4-triazol-4-amines and their cyclized products 'pyrimidinylthio pyrimidotriazolothiadiazines' as 15- lipo-oxygenase inhibitorsTayebe Asghari, Mehdi Bakavoli, Mohammad Rahimizadeh, et al.Chemical Biology & Drug Design|June 7, 2014
Design, synthesis, and pharmacological evaluation of novel 2-(4-substituted piperazin-1-yl)1, 8 naphthyridine 3-carboxylic acids as 5-HT3 receptor antagonists for the management of depressionArghya K Dhar, Radhakrishnan Mahesh, Ankur Jindal, et al.Pageof 354